Estrogen and progesterone receptors in breast cancer: correlation with clinical and pathological features and with prognosis.
Estrogen and progesterone receptor status was reviewed in 405 patients from prior adjuvant breast cancer trials at the University of Verona. Only 233 patients were actually examined with respect to hormone status and outcome. No relationship between hormone receptor status and most of the commonly followed prognostic signs, i.e. tumor size, nodal status, and age, was found. Overall survival was correlated with hormone receptor positivity for patients with more than 4 positive axillary nodes. Disease-free survival was correlated only with PgR positivity, in premenopausal and in T1 groups.
Molino
A
A
Department of Medical Oncology, University of Verona, Italy.
Turazza
M
M
Bonetti
A
A
Biondani
P
P
Griso
C
C
Adami
L
L
Corgnati
A
A
Nortilli
R
R
Pollini
G P
GP
Modena
S
S
D001943:Breast Neoplasms / Q000175:diagnosis / Q000378:metabolism* / Q000473:pathology; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008593:Menopause; D011379:Prognosis; D011960:Receptors, Estrogen / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism*; D012189:Retrospective Studies; D016019:Survival Analysis
D011960:Receptors, Estrogen; D011980:Receptors, Progesterone